The objective of establishing a centralized core laboratory facility is to make best use of the center's resources and to avoid redundance in equipment and personnel. In this core unit, we propose to establish three independent laboratories: two- dimensional electrophoresis laboratory, radioimmunoassay laboratory, and light and electron microscopy preparation laboratory. The major responsibility of this centralized core laboratory facility is to provide technical services and support to four proposed research project. Since all procedures in these laboratories require precision and repetitive manipulations, they can be best carried out by centralized, and experienced personnel. Two-dimensional electrophoresis will consist of not only the electrophoresis component but also the computerized image analysis facility. The ISO-DALT system of two-dimensional electrophoresis will be used in this laboratory. It is anticipated that approximately 800 gels will be processed by this laboratory each year. Radioimmunoassay for serum testosterone and estradiol, tissue dihydortestostrone, human serum and prostatic tissue levels of prostatic acid phosphatase and prostatic specific antigen, rat serum prolactin and dog serum leutinizing hormone has been proposed in various studies in the four research projects. All these procedures have been established in the Department of Urology. By establishing a centralized radioimmunoassay laboratory, laboratory radioimmunoassay procedures can be carried out in a very efficient manner. It also avoids the serious problems associated with scheduling efficient manner. It also avoids the serious problems associated with scheduling of instrument utilization time, if all research projects were to conduct their own radioimmunoassay analysis using the same radioactivity counting instruments. The light and electron microscopy preparation laboratory will be responsible for the processing of all specimens generated by the four research projects for light and electron microscopy. Evaluation of the sections produced by this laboratory will be the responsiblity of respective principal investigators of the four projects. Like the radioimmunoassay laboratory and the 2-D laboratory, the light and electron microscopy preparation will be centralized with in intention of efficient operation and high standard of production.

Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Northwestern University at Chicago
Department
Type
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Ilio, K Y; Nemeth, J A; Sensibar, J A et al. (2000) Prostatic ductal system in rats: changes in regional distribution of extracellular matrix proteins during castration-induced regression. Prostate 43:10-Mar
Kassen, A E; Sensibar, J A; Sintich, S M et al. (2000) Autocrine effect of DHT on FGF signaling and cell proliferation in LNCaP cells: role of heparin/heparan-degrading enzymes. Prostate 44:124-32
Lee, C; Sintich, S M; Mathews, E P et al. (1999) Transforming growth factor-beta in benign and malignant prostate. Prostate 39:285-90
Sensibar, J A; Pruden, S J; Kasjanski, R Z et al. (1999) Differential growth rates in stromal cultures of human prostate derived from patients of varying ages. Prostate 38:110-7
Sherwood, E R; Van Dongen, J L; Wood, C G et al. (1998) Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells. Br J Cancer 77:855-61
Grayhack, J T; Sensibar, J A; Ilio, K Y et al. (1998) Synergistic action of steroids and spermatocele fluid on in vitro proliferation of prostate stroma. J Urol 159:2202-9
Kim, I Y; Ahn, H J; Lang, S et al. (1998) Loss of expression of transforming growth factor-beta receptors is associated with poor prognosis in prostate cancer patients. Clin Cancer Res 4:1625-30
Kim, I Y; Zelner, D J; Lee, C (1998) The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP. Exp Cell Res 241:151-60
Grayhack, J T; Kozlowski, J M; Lee, C (1998) The pathogenesis of benign prostatic hyperplasia: a proposed hypothesis and critical evaluation. J Urol 160:2375-80
Gann, P H; Chatterton, R; Vogelsong, K et al. (1997) Epidermal growth factor-related peptides in human prostatic fluid: sources of variability in assay results. Prostate 32:234-40

Showing the most recent 10 out of 59 publications